1
|
Modaghegh MHS, Kamyar MM, Shafiei A, Shariatmaghani SS, Saremi E, Sadeghipour Kermani F. A comprehensive review of the epidemiology and clinical features of 91 cases with Buerger's disease. Vascular 2023:17085381231175257. [PMID: 37172074 DOI: 10.1177/17085381231175257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
BACKGROUND Thromboangiitis Obliterans (TAO) is a disease of small and medium-sized arteries with an unclear natural course. This study aims to establish a national registry of the disease to gain a better understanding of its epidemiology and clinical course. METHOD This study was a cohort study of 242 patients with a high probability of TAO admitted to Mashhad University of Medical Sciences (MUMS) hospitals from 2000 to 2015. Of these, 91 patients with a confirmed diagnosis were included in the study (90 males and 1 female) with a mean age of 35 ± 7.8 years. RESULTS The most common symptom upon onset of the disease was paresthesia (29.7%), followed by cold sensitivity and paresthesia (93.4%) during the progression of the disease and Raynaud syndrome or vasospasm (93.9%) in the active phase. The right lower limb was the most commonly affected limb (46.2%), and presenting ischemic symptoms in 48.4%.Statistics indicated a positive correlation between the duration of Burger's disease and the number of affected limbs (p = 0.001). There was no effect of disease duration on the likelihood of amputations (p = 0.28). CONCLUSION Some patients may experience mild, subtle symptoms for years before the initial signs and symptoms appear, which can be severe and rapidly progress to the point of requiring amputation.We suggest that the diagnostic criteria for Buerger's disease should be revised in light of the presence of atherosclerosis and its associated risk factors, which present a challenge in terms of diagnosis and treatment. Clinical experience will be of great importance in this regard.
Collapse
Affiliation(s)
- Mohammad Hadi Saeed Modaghegh
- Professor of Vascular Surgery, Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad Mahdi Kamyar
- Assistant Professor of Vascular Surgery, Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Ali Shafiei
- Assistant Professor of Vascular Surgery, Qom University of Medical Sciences, Qom, Iran
| | - Somayeh Sadat Shariatmaghani
- Assistant Professor of Internal Medicine, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Elena Saremi
- Vascular Surgeon, Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Fatemeh Sadeghipour Kermani
- Community and Preventive Medicine, Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Science, Mashhad, Iran
| |
Collapse
|
2
|
Bourgeau ME, Key PG, Chou J, Prahlow JA. Left Carotid Artery Thrombosis Due to Thromboangiitis Obliterans. Am J Forensic Med Pathol 2021; 42:297-300. [PMID: 33346979 DOI: 10.1097/paf.0000000000000646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
ABSTRACT Thromboangiitis obliterans (TAO, Buerger disease) is a segmental, non-atherosclerotic vasculitis that causes occlusion of the small and medium sized vessels of the distal extremities. In rare cases, it can affect vessels in the gastrointestinal, cerebrovascular, coronary, and renal systems. The etiology of thromboangiitis obliterans is unknown, but there is a strong association with smoking in the development and the progression of the disease. We present the case of a 42-year-old homeless female smoker, who was found dead outdoors. Although originally suspected to be a possible trauma-related death, autopsy revealed a thrombus in her left carotid artery, which caused an acute cerebral infarction. It was concluded that thromboangiitis obliterans, likely precipitated by smoking, was the cause of the thrombosis and subsequent death.
Collapse
Affiliation(s)
| | - Phillip G Key
- Department of Pathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI
| | - Jesse Chou
- Department of Pathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI
| | - Joseph A Prahlow
- Department of Pathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI
| |
Collapse
|
3
|
Bergère G, Toquet C, Hoffmann C, Bressollette L, Raimbeau A, Durant C, Artifoni M, Gautier G, Hersant J, Connault J, Pistorius MA, Espitia O. Effect of cannabis consumption on characteristics and evolution of thromboangitis obliterans. VASA 2021; 50:301-305. [PMID: 33739143 DOI: 10.1024/0301-1526/a000948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Background: Thromboangiitis obliterans (TAO) is a distal non atherosclerotic thrombotic vasculitis affecting tobacco smokers. The role of cannabis co-exposure remains controversial. The study aims to assess how cannabis consumption influences clinical presentation and outcome of TAO in tobacco smokers. Patients and methods: TAO patients, according to Papa's criteria, were included in a retrospective bicentric study between the 1st January 2003 and the 1st march 2020. Clinical characteristics, arterial involvement at TAO diagnosis, vascular event and amputations during follow-up were analyzed according to cannabis consumption. Results: Seventy-three patients with TAO patients were included. Forty-five patients were in Tobacco group (T) and 28 in Tobacco and cannabis group (T&C). Tobacco exposure was less important in T&C group than in T group (19.4±11.3 vs 31.6±16.6 pack-years) (p=0.005) and patients in T&C group were younger at TAO diagnosis than in T group (p=0.008). Patients in T&C group presented more claudication (33.3% vs 8.9%, p=0.01) and less upper limbs resting ischemia (25.9% vs 51.1%, p=0.04) than patients in the T group. No differences were found between groups with regard to arterial distribution. Amputation rate for patients who had at least one major or minor amputation did not differ between T and T&C group (25% vs 14.8%, p=0.38). Conclusions: Cannabis consumption was associated with a younger age of TAO onset. However, it does not affect amputation-free survival, Tobacco exposure is less important in T&C patients; data of this bicentric study suggest that cannabis could be a cofactor of tobacco which accelerates TAO onset.
Collapse
Affiliation(s)
- Guillaume Bergère
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | | | - Clément Hoffmann
- Department of vascular medicine, EA 3878 GETBO, CHU de Brest, France
| | - Luc Bressollette
- Department of vascular medicine, EA 3878 GETBO, CHU de Brest, France
| | - Alizée Raimbeau
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | - Cécile Durant
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | - Mathieu Artifoni
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | - Giovanni Gautier
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | - Jeanne Hersant
- Department of internal and vascular medicine, CHU de Nantes, France
| | - Jérôme Connault
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | - Marc-Antoine Pistorius
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| | - Olivier Espitia
- Department of internal and vascular medicine, CHU de Nantes, France.,UNAV, Nantes vascular access unit, CHU de Nantes, France
| |
Collapse
|
4
|
Soudet S, Le Joncour A, Quemeneur T, Maillard H, Koskas F, Hachulla E, Cacoub P, Yelnik CM, Saadoun D, Lambert M. Did the Clinical Spectrum of Thromboangiitis Obliterans Change in the Past 40 Years? Angiology 2020; 71:621-625. [PMID: 32319306 DOI: 10.1177/0003319720920163] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Thromboangiitis obliterans (TAO) is an inflammatory disease that usually affects small and medium-sized arteries in the upper and lower limbs of young smokers. Previous studies showed that the spectrum TAO has changed in the 80s: the male-to-female ratio decreased, older patients were diagnosed, and upper limb involvement was more common. The aim of our study was to assess the changing clinical spectrum of TAO in France during the past 40 years. All consecutive patients fulfilling TAO's criteria between January 1967 and January 2016 were retrospectively included in 3 departments of internal medicine. We compared TAO features in patients diagnosed before and after 2002; 141 (77.5%) men and 41 (22.5%) women were included. Patients diagnosed after 2002 were older (37 [31-39] vs 34 [29-35] years P = .03), had a more frequent isolated upper limb involvement (34.3% vs 7.8% P = .001), and less frequent isolated lower limb involvement (55.7% vs 74.5%, P < .001). The clinical spectrum of TAO has changed in France since the beginning of the 21st century.
Collapse
Affiliation(s)
- Simon Soudet
- Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France
| | - Alexandre Le Joncour
- Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l'Amylose, Paris, France.,AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France
| | - Thomas Quemeneur
- Department of Nephrology and Internal Medicine, Valenciennes Hospital, France
| | - Helene Maillard
- Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France
| | - Fabien Koskas
- Department of Vascular Surgery, Assistance Publique des Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Paris, France
| | - Eric Hachulla
- Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France
| | - Patrice Cacoub
- Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l'Amylose, Paris, France.,AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France
| | - Cecile M Yelnik
- Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France
| | - David Saadoun
- Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares, des Maladies Auto-Inflammatoires et de l'Amylose, Paris, France.,AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, UPMC Univ Paris 06, UMR 7211, France
| | - Marc Lambert
- Department of Internal Medicine, Hôpital HURIEZ, CHRU Lille, France
| |
Collapse
|
5
|
Ehteshamfar SM, Afshari JT, Modaghegh MHS, Mahmoudi M, Kazemzadeh GH, Kermani FS. Humoral and cellular immune response to Buerger's disease. Vascular 2020; 28:457-464. [PMID: 32212917 DOI: 10.1177/1708538120910055] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
OBJECTIVE Thromboangiitis obliterans is a nonatherosclerotic occlusive disease, affecting small to moderate sized arteries of the upper and lower extremities, leading to progressive inflammation and clot formation. However, the role of humoral and cell-mediated immunity in the development of this disease has not been clearly identified. The present study was intended to investigate the humoral and cellular immune response in patients with Buerger's disease with different disease severity. METHODS In an observational study, 80 male patients with Buerger's disease were included and categorized into three groups (mild, moderate, and severe) based on clinical manifestations. After blood sampling, cellular phenotypes were determined, and erythrocyte sedimentation rate, immunoglobulins (Ig) A, M, G, and E, as well as C3 and C4 components of the complement system and complement hemolytic activity (CH50) were measured. RESULTS The mean age of the patient was 42.85 ± 8.39 years. Pulse abnormality, cold intolerance, and claudication were the most common symptoms. Eleven (13.75%), 46 (57.50%), and 23 (28.75%) patients had mild, moderate, and severe symptoms. Regression analyses showed that the presence of severe symptoms was significantly associated with elevated erythrocyte sedimentation rate and C4 levels (p < 0.05). CONCLUSION Buerger's disease in severe cases was associated with increased erythrocyte sedimentation rate and abnormal C4 levels. The alterations in these inflammatory biomarkers might be due to a secondary inflammatory response to the presence of ulcer or gangrene and the inflammatory process in patients with severe symptoms.
Collapse
Affiliation(s)
| | - Jalil Tavakkol Afshari
- Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad-Hadi S Modaghegh
- Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mahmoud Mahmoudi
- Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Gholam Hosein Kazemzadeh
- Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | | |
Collapse
|
6
|
Shapouri-Moghaddam A, Saeed Modaghegh MH, Rahimi HR, Ehteshamfar SM, Tavakol Afshari J. Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES 2019; 22:215-224. [PMID: 31156780 PMCID: PMC6528722 DOI: 10.22038/ijbms.2019.31119.7513] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Thromboangiitis obliterans (TAO) is a thrombotic-occlusive as well as an inflammatory peripheral vascular disease with unknown etiology. Recent evidence has supported the immunopathogenesis of the disease, however, the factors contributing to the altered immune function and vascular tissue inflammation are still unclear. This review was intended to collate the more current knowledge on the regulatory molecules involved in TAO from an immunoreactive perspective. The homeostasis of the immune system as well as a variety of progenitor cell populations appear to be affected during TAO and these alterations are associated with intrinsic signaling defects that are directing to an improved understanding of the crosstalk between angiogenesis and the immune system, as well as the potential of new co-targeting strategies applying both immunotherapy and angiogenic therapy.
Collapse
Affiliation(s)
- Abbas Shapouri-Moghaddam
- Immunology Research Group, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Hamid Reza Rahimi
- Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Seyyed-Morteza Ehteshamfar
- Immunology Research Group, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Jalil Tavakol Afshari
- Immunology Research Group, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|
7
|
Le Joncour A, Soudet S, Dupont A, Espitia O, Koskas F, Cluzel P, Hatron PY, Emmerich J, Cacoub P, Resche‐Rigon M, Lambert M, Saadoun D. Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients. J Am Heart Assoc 2018; 7:e010677. [PMID: 30571594 PMCID: PMC6405548 DOI: 10.1161/jaha.118.010677] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2018] [Accepted: 10/08/2018] [Indexed: 01/04/2023]
Abstract
Background Data regarding long-term outcome of patients with thromboangiitis obliterans are lacking and most series come from India and Japan. In this study, we assess long-term outcome and prognostic factors in a large cohort of thromboangiitis obliterans. Methods and Results Retrospective multicenter study of characteristics and outcomes of 224 thromboangiitis obliterans patients fulfilling Papa's criteria were analyzed. Factors associated with vascular events and amputations were identified. The median age at diagnosis was 38.5 (32-46) years, 51 (23.8%) patients were female, and 81.7% were whites. After a mean follow-up of 5.7 years, vascular events were observed in 58.9%, amputations in 21.4%, and death in 1.4%. The 5-, 10-, and 15-year vascular event-free survival and amputation-free survival were 41% and 85%, 23% and 74%, and 19% and 66%, respectively. Ethnic group (nonwhite) (hazard ratio 2.35 [1.30-4.27] P=0.005) and limb infection at diagnosis (hazard ratio 3.29 [1.02-10.6] P=0.045) were independent factors of vascular event-free survival. Factor associated with amputation was limb infection (hazard ratio 12.1 [3.5-42.1], P<0.001). Patients who stopped their tobacco consumption had lower risk of amputation ( P=0.001) than those who continued. Conclusions This nationwide study shows that 34% of thromboangiitis obliterans patients will experience an amputation within 15 years from diagnosis. We identified high-risk patients for vascular complications and amputations.
Collapse
Affiliation(s)
- Alexandre Le Joncour
- UPMC Univ Paris 06UMR 7211, and Inflammation‐Immunopathology‐Biotherapy Department (DHU i2B)Sorbonne UniversitésParisFrance
- UMR_S 959INSERMParisFrance
- Department of Internal Medicine and Clinical ImmunologyAP‐HPGroupe Hospitalier Pitié‐SalpêtrièreParisFrance
- Centre national de référence des maladies Autoimmunes Systémiques raresCentre National de Référence Des Maladies Autoinflammatoires et de l'AmyloseFrance
| | - Simon Soudet
- Département de Médecine Interne et Immunologie CliniqueCHU LilleLilleFrance
- Centre National de Référence des Maladies Autoimmunes et Systémiques Rares (Sclérodermie)France
| | - Axelle Dupont
- Service de Biostatistique et Information médicaleAPHPHôpital Saint‐LouisParisFrance
| | | | - Fabien Koskas
- Service de chirurgie vasculaireGroupe Hospitalier Pitié‐SalpétrièreParisFrance
| | - Philippe Cluzel
- Service d'Imagerie CardiovasculaireInstitut de cardiologieGroupe Hospitalier Pitié‐SalpétrièreParisFrance
| | - Pierre Yves Hatron
- Département de Médecine Interne et Immunologie CliniqueCHU LilleLilleFrance
- Centre National de Référence des Maladies Autoimmunes et Systémiques Rares (Sclérodermie)France
| | - Joseph Emmerich
- Department of Vascular Medicine and CardiologyUniversity Hospital Hotel DieuUniversity Paris‐DescartesParisFrance
| | - Patrice Cacoub
- UPMC Univ Paris 06UMR 7211, and Inflammation‐Immunopathology‐Biotherapy Department (DHU i2B)Sorbonne UniversitésParisFrance
- UMR_S 959INSERMParisFrance
- Department of Internal Medicine and Clinical ImmunologyAP‐HPGroupe Hospitalier Pitié‐SalpêtrièreParisFrance
- Centre national de référence des maladies Autoimmunes Systémiques raresCentre National de Référence Des Maladies Autoinflammatoires et de l'AmyloseFrance
| | | | - Marc Lambert
- Département de Médecine Interne et Immunologie CliniqueCHU LilleLilleFrance
- Centre National de Référence des Maladies Autoimmunes et Systémiques Rares (Sclérodermie)France
| | - David Saadoun
- UPMC Univ Paris 06UMR 7211, and Inflammation‐Immunopathology‐Biotherapy Department (DHU i2B)Sorbonne UniversitésParisFrance
- UMR_S 959INSERMParisFrance
- Department of Internal Medicine and Clinical ImmunologyAP‐HPGroupe Hospitalier Pitié‐SalpêtrièreParisFrance
- Centre national de référence des maladies Autoimmunes Systémiques raresCentre National de Référence Des Maladies Autoinflammatoires et de l'AmyloseFrance
| | | |
Collapse
|
8
|
Kacmaz F, Kaya A, Keskin M, Keceoglu S, Algin IH, Yilmazkaya B, Ilkay E. Clinical outcomes of extended endovascular recanalization of 16 consecutive Buerger’s disease patients. Vascular 2018; 27:233-241. [DOI: 10.1177/1708538118805623] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Objective Buerger’s disease is one of the worst diseases causing peripheral artery occlusions (especially lower extremity) with increased morbidity and mortality. Endovascular treatment of the diseased arteries gains preference over bypass surgery nowadays. Here, we aimed to present the clinical outcomes of 16 consecutive Buerger’s disease patients underwent extended endovascular recanalization which is a new technique to restore direct blood flow to at least one foot artery, with the performance of angioplasty for each tibial and foot artery obstructions. Methods A total of 16 consecutive patients with confirmed diagnosis of Buerger’s disease that percutaneously treated in our center between February 2014 and March 2018 were included in the study. The mean age of the patients was 44.25 ± 4.28 ranging from 36 to 50 years. After physical examination and complementary diagnostic tests, performance of extended angioplasty for occluded arteries was intended to restore direct blood flow to at least one of the blow-the-knee arteries. Results A successful extended endovascular treatment was performed in 20 of 22 limbs, achieving a technical success of 91%. All patients were successfully discharged without any complication. Mean follow-up duration was 21.43 ± 7.08 months. Reintervention was performed in one patient and minor amputation was needed in one of the failed limbs. Limb salvage rate was 100%. A significant difference was observed based on Rutherford classification, ankle brachial index, direct blood flow to foot, presence of ulcer and rest pain when compared before and after the intervention. Conclusion We showed successful extended endovascular recanalization of Buerger’s disease patients with a high technical success rate and sustained clinical improvement. Extended endovascular recanalization could be a therapeutic option in Buerger’s disease patients, since they are not good candidates for surgery.
Collapse
Affiliation(s)
- Fehmi Kacmaz
- Cardiology, Hasan Kalyoncu University, Gaziantep, Turkey
| | - Adnan Kaya
- Cardiology, Duzce University, School of Medicine, Duzce, Turkey
| | - Muhammed Keskin
- Cardiology, Sultan Abdul Hamid Han Research and Training Hospital, Istanbul, Turkey
| | | | | | - Bayram Yilmazkaya
- Cardiovascular Surgery, NCR International Hospital, Gaziantep, Turkey
| | | |
Collapse
|
9
|
Wu S, Sun X, Wu W, Shi D, Jiang T. Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans. Exp Ther Med 2018; 15:3947-3951. [PMID: 29556267 PMCID: PMC5844100 DOI: 10.3892/etm.2018.5877] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2017] [Accepted: 02/01/2018] [Indexed: 11/12/2022] Open
Abstract
The aim of the study was to investigate the effects of revascularization in treating patients with thromboangiitis obliterans (TAO), to analyze the prognosis of TAO. The treatment group comprised 32 patients with TAO of lower limbs who were selected between March 2012 and March 2017. Patients in the treatment group were treated with revascularization (vascular bypass surgery, catheter-directed thrombolysis and angioplasty, endovascular angioplasty + stening, thromboectomy and/or endarterectomy) + Western medicine. Another 33 patients with TAO who were treated with Western medicine alone comprised the control group. Treatment outcomes were compared between the groups. Serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-α (TNF-α) were also detected and compared between the groups. Multivariate analysis was performed to identify the factors related to prognosis. Compared with control group, treatment outcomes were significantly better in the treatment group (P<0.05). After treatment, the serum levels of IL-6, IL-8 and TNF-α significantly decreased in both groups, and the decrease in the treatment group was more significant (P<0.01). Multivariate analysis revealed that vascular bypass surgery and preoperative ischemic degree are associated with treatment effect. Our results show that revascularization treatment of TAO is conducive to clinical symptoms and dysfunction of inflammatory cytokines, and the type of surgery and surgical timing significantly affect treatment outcomes.
Collapse
Affiliation(s)
- Shifeng Wu
- Department of Burns and Plastic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
| | - Xin Sun
- Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
| | - Wei Wu
- Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
| | - Dazhi Shi
- Department of Intensive Care Unit, The Fourth Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
| | - Tao Jiang
- Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
| |
Collapse
|
10
|
Modaghegh MHS, Hafezi S. Endovascular Treatment of Thromboangiitis Obliterans (Buerger’s Disease). Vasc Endovascular Surg 2017; 52:124-130. [DOI: 10.1177/1538574417744085] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Purpose: When critical limb ischemia (CLI) occurs in patients with thromboangiitis obliterans (TAO) or Buerger’s disease, smoking cessation alone may be insufficient to relieve rest pain and promote wound healing. Accordingly, adjunctive measures are warranted to restore adequate blood flow required for limb salvage. This study aimed to evaluate the feasibility and efficacy of percutaneous transluminal angioplasty (PTA) for the treatment of patients with TAO and CLI. In addition, a review of the literature on endovascular management of TAO is included. Methods: Between April 2012 and June 2017, all patients with TAO and CLI who underwent PTA were studied retrospectively. Patient demographics, presentation, procedural details, and clinical response were recorded. Patients were monitored at 1 week, 1, 2, 3, and 6 months after revascularization and at least every 6 months thereafter. Results: Thirteen patients with TAO and CLI, who presented with rest pain only (n = 1), ischemic ulcer (n = 4), or gangrene (n = 8) underwent endovascular interventions with primary and assisted primary technical success of 85% and 92%, respectively. A below-knee amputation was eventually done in the only patient with technical failure (limb salvage rate: 92%). Following the procedures, 11 patients had clinical response, one of whom also received intra-arterial vasodilator to achieve complete symptom relief. The other patient who failed PTA underwent a successful lumbar sympathectomy. In addition, all ulcers healed and eight minor amputations were performed due to already established gangrene. During follow-up (mean: 19.4 months), four patients needed reintervention. Patients who continued to smoke experienced more severe ischemia ( P = .017) and were more likely to require reintervention ( P = .009). Conclusion: Percutaneous transluminal angioplasty can be considered as a technically feasible and potentially effective treatment for patients with TAO and CLI, as well as a last resort for limb salvage when other options have failed. However, reintervention may be required, especially in patients who continue smoking.
Collapse
Affiliation(s)
- Mohammad-Hadi S. Modaghegh
- Vascular and Endovascular Surgery Research Center, Alavi Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Shahab Hafezi
- Vascular and Endovascular Surgery Research Center, Alavi Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|